Unknown

Dataset Information

0

Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants.


ABSTRACT: To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis.Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) were matched to cases by age, race, and county of residence.After adjustment for confounders, subjects who were heterozygous or homozygous for the variant allele of the hOGG1 Ser326Cys polymorphism appeared to experience a lower risk of prostate cancer than those who were homozygous for the wild-type allele (odds ratio [OR] (95% confidence interval [CI]): 0.72 (0.46-1.10)]. Conversely, a significant increased risk was observed for individuals who carried 1 or 2 copies of the variant allele of the XRCC1 Arg399Gln polymorphism, compared with those who only harbored the wild-type allele (OR [95% CI]: 1.56 [1.01-2.45]). The above-mentioned associations were generally more pronounced among subjects with low plasma carotenoids or alpha-tocopherol (

SUBMITTER: Zhang J 

PROVIDER: S-EPMC2850942 | biostudies-literature | 2010 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants.

Zhang Jianjun J   Dhakal Ishwori B IB   Greene Graham G   Lang Nicholas P NP   Kadlubar Fred F FF  

Urology 20091114 4


<h4>Objectives</h4>To investigate whether polymorphisms in genes involved in the repair of oxidative DNA damage, modulate, and/or interact with antioxidants to influence prostate cancer risk in a population-based case-control study in Central Arkansas. Accumulating evidence indicates that oxidative stress plays a role in prostate carcinogenesis.<h4>Methods</h4>Cases (n = 193) included men aged 40-80 years, diagnosed with prostate cancer in 3 major hospitals in 1998-2003, and controls (n = 197) w  ...[more]

Similar Datasets

| S-EPMC3207491 | biostudies-literature
| S-EPMC2890553 | biostudies-literature
| S-EPMC4415422 | biostudies-other
| S-EPMC3980033 | biostudies-literature
| S-EPMC1865553 | biostudies-literature
| S-EPMC3601005 | biostudies-literature
| S-EPMC4047147 | biostudies-literature
| S-EPMC3767803 | biostudies-literature
| S-EPMC6277639 | biostudies-literature
| S-EPMC8795906 | biostudies-literature